Biocon

is an India-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes, cancer and autoimmune diseases...
Read more
Biocon CEO: Peter Bains

CEO

Peter Bains

CEO Approval Rating

68/100

1978

Bangalore
Karnataka

PublicMerged with Biosimilars Division, Viatris Inc.National Stock Exchange of IndiaBIOCON

2834 NAICS listing
Annual Revenue
$1.9B
Employees
16,315
Funding
$129.4M
Acquisitions
3
Investments
1

Biocon Competitors

1Wockhardt
2Cipla
3Intas
4Emcure
5Bharat Serums
6NATCO Pharma Limited
7Dr.Reddy's
8Novo
9USV Limited
10AryoGen Pharmed

Trending Companies